Robert Ledeen

academic, NJMS-Pharmacology

Emailledeenro@rutgers.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Robert Ledeen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

10 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

6 Finished

SPHINGOLIPIDS AS SIGNALING MODULATORS IN NERVOUS SYSTEM
Ledeen, R.
National Institute of Neurological Disorders and Stroke
7/1/97 → 6/30/98
Project: Research project
NUCLEAR GM1--ROLE IN NEURONAL DIFFERENTATION
Ledeen, R., LEDEEN, R. & LEDEEN, R. W.
National Institute of Neurological Disorders and Stroke
4/22/96 → 6/30/13
Project: Research project
STUDY OF NERVOUS SYSTEM GANGLIOSIDES AND RELATED LIPIDS
Ledeen, R. & Ledeen, R.
National Institute of Neurological Disorders and Stroke, National Institutes of Health
12/31/89 → 11/30/94
Project: Research project
STUDY OF MYELIN ENZYMES &RECEPTORS &THE AXON
Ledeen, R. & Ledeen, R.
National Institutes of Health, National Institute of Neurological Disorders and Stroke
12/31/89 → 5/31/99
Project: Research project
NEUTRAL GLYCOSPHINGOLIPIDS OF DEVELOPING NERVOUS SYSTEM
Ledeen, R., Ledeen, R. & LEDEEN, R.
National Institutes of Health, National Institute of Neurological Disorders and Stroke
12/31/89 → 12/31/91
Project: Research project

8139 Citations
46 h-Index
136 Article
14 Review article
3 Conference contribution
2 Chapter
More
- 2 Comment/debate
- 1 Editorial

Mice deficient in GM1 manifest both motor and non-motor symptoms of Parkinson's disease; successful treatment with synthetic GM1 ganglioside
Wu, G., Lu, Z. H., Seo, J. H., Alselehdar, S. K., DeFrees, S. & Ledeen, R. W., Jul 2020, In: Experimental Neurology. 329, 113284.
Research output: Contribution to journal › Article › peer-review
5 Scopus citations
Parkinson’s disease recovery by GM1 oligosaccharide treatment in the B4galnt1 ^+/− mouse model
Chiricozzi, E., Mauri, L., Lunghi, G., Di Biase, E., Fazzari, M., Maggioni, M., Valsecchi, M., Prioni, S., Loberto, N., Pomè, D. Y., Ciampa, M. G., Fato, P., Verlengia, G., Cattaneo, S., Assini, R., Wu, G., Alselehdar, S., Ledeen, R. W. & Sonnino, S., Dec 1 2019, In: Scientific reports. 9, 1, 19330.
Research output: Contribution to journal › Article › peer-review

Open Access
12 Scopus citations
Gangliosides of the nervous system
Ledeen, R. & Wu, G., 2018, Methods in Molecular Biology. Humana Press Inc., p. 19-55 37 p. (Methods in Molecular Biology; vol. 1804).
Research output: Chapter in Book/Report/Conference proceeding › Chapter
22 Scopus citations
Glycan Chains of Gangliosides: Functional Ligands for Tissue Lectins (Siglecs/Galectins)
Ledeen, R. W., Kopitz, J., Abad-Rodríguez, J. & Gabius, H. J., Jan 1 2018, Progress in Molecular Biology and Translational Science. Schnaar, R. L. & Lopez, P. H. H. (eds.). Elsevier B.V., p. 289-324 36 p. (Progress in Molecular Biology and Translational Science; vol. 156).
Research output: Chapter in Book/Report/Conference proceeding › Chapter
14 Scopus citations
Galectins: their network and roles in immunity/tumor growth control
Kaltner, H., Toegel, S., Caballero, G. G., Manning, J. C., Ledeen, R. W. & Gabius, H. J., Feb 1 2017, In: Histochemistry and Cell Biology. 147, 2, p. 239-256 18 p.
Research output: Contribution to journal › Review article › peer-review
80 Scopus citations